A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.
A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (the CKD) in military populations and the challenges of tracking these factors.
“A growing body of evidence suggests that negative SDOH—or social risks—contribute to socioeconomic and racial disparities in CKD,” researchers wrote.1 “One mechanism through which social risks appear to produce disease is by impeding access to healthcare.”
Using data from the Military Health System (MHS), researchers assessed CKD disparities in the context of universal health care. All MHS beneficiaries between the ages of 18 and 64 who received care from the MHS from October 2015 through September 2018 were included in the analysis. International Classification of Disease, 10th Revision (ICD-10), codes and/or validated laboratory value-based electronic phenotypes constituted CKD incidence.
The investigators used multivariable logistic regression models to compare the prevalence of CKD by race, rank, and other factors while controlling separately for confounders.
A total of 3,330,893 beneficiaries were included in the analysis, of whom 105,504 (3.2%) had CKD. Confounder-adjusted models showed, “CKD prevalence was statistically elevated in beneficiaries of Black vs White race, lower vs higher rank (as a proxy for socioeconomic status), lower vs higher income, and married vs single status (P <.0001).”
However, associations were mitigated when adjusting for suspected mediators, “indicating the mediators may indeed be on the causal pathway between social risks and CKD,” the researchers wrote. The findings also suggest social factors remain pertinent despite access to universal health care coverage.
In a separate analysis,2 investigators found low documentation of SDOH among US veterans and Medicare patients with CKD. In 2015, implementation of ICD-10 codes included new Z-codes to specifically identify SDOH. In this investigation, the researchers “sought to identify differences in SDOH-related Z-code (SDOH-ZC) utilization in Veterans Health Administration and Medicare patients, identifying differences in SDOH-ZC utilization in those with and without CKD.”
The study included a 5% sample of Medicare claims data from 2015 to 2018 and 100% of VA health data amassed during the same time period. SDOH-ZCs were grouped into 17 categories such as employment status, housing, and economic circumstances.
The researchers measured the proportion of claims assigned a SDOH-ZC quarterly across different health care encounters and described by patient demographic and medical characteristics. Code use was then compared between those with CKD and those without.
Analyses revealed:
“We observed lower recording of SDOH overall and among those with CKD in health care settings,” the authors concluded. “Additional efforts might consider increasing SDOH documentation to help assess need for social services, which could potentially reduce disparities in health outcomes by socioeconomic status.”
References
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More